WFNMB
Scientific Reports has opened a Collection on targeted radiopharmaceuticals, with WARMTH's Kalevi Kairemo among the guest editors. Submissions close 13 February 2027.
Scientific Reports has opened a Collection on targeted radiopharmaceuticals, inviting research into their development and use in preclinical models and clinical studies. Radioligands have advanced diagnostic imaging and therapy across cancer, Alzheimer’s disease and other conditions; coupling them to peptides, antibodies or small molecules for precision targeting can improve efficacy, reduce side effects and open theragnostic options.
The Collection is recognised for its contribution to UN Sustainable Development Goal 3.
Guest editors: Kalevi Kairemo (Docrates Cancer Center, Finland); Kitiwat Khamwan (Chulalongkorn University, Thailand); Kel Vin Tan (Perceptive Inc, United Kingdom); Anzhelika Vorobyeva (Uppsala University, Sweden).